3D gene hubs: Researchers find DNA folding in brain cell nuclei may be key to understanding glioblastoma cancer

Updated on: May 21,2025 0

3D gene hubs: Researchers find DNA folding in brain cell nuclei may be key to understanding glioblastoma cancer

Updated on:May 21,2025 0

Simultaneously targeting lysosomal enzyme and KRAS-MAPK pathway eradicates pancreatic tumors in preclinical models

Updated on: May 21,2025 0

Simultaneously targeting lysosomal enzyme and KRAS-MAPK pathway eradicates pancreatic tumors in preclinical models

Updated on:May 21,2025 0

Tumor byproduct blocks immune cells from fighting cancer, offering new treatment target

Updated on: May 21,2025 0

Tumor byproduct blocks immune cells from fighting cancer, offering new treatment target

Updated on:May 21,2025 0

Medical marijuana can help cancer patients, finds a large meta-analysis

Updated on: May 21,2025 0

Medical marijuana can help cancer patients, finds a large meta-analysis

Updated on:May 21,2025 0

Novel antibiotic BTZ-043 can also target TB bacteria hiding in dead lung tissue

Updated on: March 28,2025 0

Novel antibiotic BTZ-043 can also target TB bacteria hiding in dead lung tissue

Updated on:March 28,2025 0

A new druggable cancer target: RNA-binding proteins on the cell surface

Updated on: May 21,2025 0

A new druggable cancer target: RNA-binding proteins on the cell surface

Updated on:May 21,2025 0

Certain glucose-lowering meds associated with lower risk for COPD exacerbations

Updated on: March 27,2025 0

Certain glucose-lowering meds associated with lower risk for COPD exacerbations

Updated on:March 27,2025 0

California clinicians boost buprenorphine prescriptions, aiding recovery efforts

Updated on: March 28,2025 0

California clinicians boost buprenorphine prescriptions, aiding recovery efforts

Updated on:March 28,2025 0

NIH research funding drops $1B under Trump administration

Updated on: March 29,2025 0

NIH research funding drops $1B under Trump administration

Updated on:March 29,2025 0

FDA approves Romvimza for tenosynovial giant cell tumor (TGCT)

Updated on: March 28,2025 0

FDA approves Romvimza for tenosynovial giant cell tumor (TGCT)

Updated on:March 28,2025 0